AZD1283 - CAS 919351-41-0
Catalog number:
919351-41-0
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
P2Y Receptor
Description:
AZD1283 dose-dependently induced increases in blood flow and inhibition of ADP-induced platelet aggregation with antithrombotic ED50 values of 3.0 and 10 μg/kg/min, respectively. The doses that induced a larger than 3-fold increase in bleeding time were 33 and 100 μg/kg/min for 3 and 13, respectively. Thus, the therapeutic index (TI) was ≥10 for both compounds. On the basis of these data, compound 3 was progressed into human clinical trials as candidate drug AZD1283
Publictions citing BOC Sciences Products
  • >> More
Purity:
0.98
Appearance:
white to off-white solid powder
Synonyms:
AZD 1283; AZD-1283
MSDS:
Inquire
1.Lead optimization of ethyl 6-aminonicotinate acyl sulfonamides as antagonists of the P2Y12 receptor. separation of the antithrombotic effect and bleeding for candidate drug AZD1283.
Bach P1, Antonsson T, Bylund R, Björkman JA, Österlund K, Giordanetto F, van Giezen JJ, Andersen SM, Zachrisson H, Zetterberg F. J Med Chem. 2013 Sep 12;56(17):7015-24. doi: 10.1021/jm400820m. Epub 2013 Aug 29.
Synthesis and structure-activity relationships of ethyl 6-aminonicotinate acyl sulfonamides, which are potent antagonists of the P2Y12 receptor, are presented. Shifting from 5-chlorothienyl to benzyl sulfonamides significantly increased the potency in the residual platelet count assay. Evaluation of PK parameters in vivo in dog for six compounds showed a 10-fold higher clearance for the azetidines than for the matched-pair piperidines. In a modified Folts model in dog, both piperidine 3 and azetidine 13 dose-dependently induced increases in blood flow and inhibition of ADP-induced platelet aggregation with antithrombotic ED50 values of 3.0 and 10 μg/kg/min, respectively. The doses that induced a larger than 3-fold increase in bleeding time were 33 and 100 μg/kg/min for 3 and 13, respectively. Thus, the therapeutic index (TI) was ≥ 10 for both compounds. On the basis of these data, compound 3 was progressed into human clinical trials as candidate drug AZD1283.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related P2Y Receptor Products


Prasugrel Maleic acid
(CAS: 389574-20-3)

Prasugrel is a platelet inhibitor (IC50=1.8 μM) , as a third-generation thienopyridine.

CAS 150322-43-3 Prasugrel

Prasugrel
(CAS: 150322-43-3)

Prasugrel is a thienopyridine prodrug that is converted by esterases to a receptor antagonist for purinergic P2Y12 receptors. The blockade of P2Y12 receptor act...

Clopidogrel thiolactone
(CAS: 1147350-75-1)

The thiolactone form of Clopidogrel that could be an effective antiplatelet agent for behaving as an inhibitor of P2Y12 receptor.

CAS 120202-66-6 Clopidogrel

Clopidogrel
(CAS: 120202-66-6)

Clopidogrel is converted to its active metabolite by cytochrome P450 (CYP) enzymes.

Regrelor
(CAS: 787548-03-2)

Regrelor is a P2Y12 antagonist. In Dec 2008, Phase-II for Thrombosis in USA was discontinued.

CAS 274693-27-5 Ticagrelor

Ticagrelor
(CAS: 274693-27-5)

Ticagrelor, the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in...

CAS 711019-86-2 MRS 2578

MRS 2578
(CAS: 711019-86-2)

MRS2578 is a potent P2Y6 receptor antagonist with IC50 of 37 nM, exhibits insignificant activity at P2Y1, P2Y2, P2Y4,and P2Y11 receptors.

CAS 145-63-1 Suramin

Suramin
(CAS: 145-63-1)

Suramin, also called as Germanin, has been demonstrated to inhibit a large variety of enzymes including urease, hexokinase, succinic dehydrogenase, p-glucuronid...

CAS 919351-41-0 AZD1283

AZD1283
(CAS: 919351-41-0)

AZD1283 dose-dependently induced increases in blood flow and inhibition of ADP-induced platelet aggregation with antithrombotic ED50 values of 3.0 and 10 μg/kg/...

CAS 113665-84-2 Clopidogrel

Clopidogrel
(CAS: 113665-84-2)

Clopidogrel, a thienopyridine derivative, could be used in the prevention and treatment of sorts of arterial circulation disorders caused by platelet aggregatio...

CAS 129-46-4 Suramin Sodium

Suramin Sodium
(CAS: 129-46-4)

The sodium salt of Suramin which is a P2 purinergic antagonist and has been also found to have the effect in blocking the G protein binds to GPCRs so that it wa...

CAS 318250-11-2 INS37217

INS37217
(CAS: 318250-11-2)

INS-37217, also known as Denufosol, is a long- acting P2Y2 receptor agonist potentially for the treatment of cystic fibrosis. INS-37217 exhibits an EC50 of ~10 ...

CAS 211427-08-6 Diquafosol tetrasodium

Diquafosol tetrasodium
(CAS: 211427-08-6)

Diquafosol tetrasodium, also referred to Diquas, is aP2Y2receptor agonist that is targeted to treat dry eye disease through rehydration of the ocular surface.

CAS 163706-06-7 Cangrelor

Cangrelor
(CAS: 163706-06-7)

Cangrelor, an adenylic acid derivative, has been found to be a P2Y12 inhibitor that could be effective in some coronary artery diseases. It is under Phase I tri...

N6-(4-Hydroxybenzyl)adenosine
(CAS: 110505-75-4)

N6-(4-Hydroxybenzyl)adenosine, an imidazopyrimidine derivative, could be effective as an inhibitor of platelet aggregation. IC50: 6.77-141 μM.

CAS 389574-19-0 Prasugrel Hydrochloride

Prasugrel Hydrochloride
(CAS: 389574-19-0)

Prasugrel is a platelet inhibitor (IC50=1.8 μM) , as a third-generation thienopyridine.

Chemical Structure

CAS 919351-41-0 AZD1283

Quick Inquiry

Verification code

Featured Items